DiaMedica Therapeutics
(NASDAQ:DMAC)
$3.43
0.18[5.54%]
Last update: 4:18PM Get Real Time Here
Q1 2024 Earnings were released on Wed May 8th, after the market close
The most recent conference call was at 8:00 AM, 1 day ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

DiaMedica Therapeutics Stock (NASDAQ:DMAC), Quotes and News Summary

DiaMedica Therapeutics Stock (NASDAQ: DMAC) stock price, news, charts, stock research, profile.

Open$3.290
Close-
Volume / Avg.642.000 / 42.849K
Day Range3.290 - 3.290
52 Wk Range1.580 - 4.750
Market Cap$130.196M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
0.74%
Days to Cover3.33

Recent News

DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a 
Nabaparna Bhattacharya
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DMAC

FAQ

Q

How do I buy DiaMedica Therapeutics (DMAC) stock?

A

You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are DiaMedica Therapeutics's (DMAC) competitors?

A

There are no as such competitors for DiaMedica Therapeutics.

Q

What is the target price for DiaMedica Therapeutics (DMAC) stock?

A

The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Craig-Hallum on Wednesday, April 24, 2024. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 133.24% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for DiaMedica Therapeutics (DMAC)?

A

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $3.43 last updated May 8, 2024 at 4:18 PM EDT.

Q

Does DiaMedica Therapeutics (DMAC) pay a dividend?

A

There are no upcoming dividends for DiaMedica Therapeutics.

Q

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

A

DiaMedica Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Q

Is DiaMedica Therapeutics (DMAC) going to split?

A

There is no upcoming split for DiaMedica Therapeutics.

Q

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

A

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.